KYTHERA Biopharmaceuticals's President & CEO just disposed of 3,656 shares


Keith R Leonard, KYTHERA Biopharmaceuticals's President & CEO and a director of the company, recently disposed of 3,656 shares of the company. The disposals took place at prices ranging from $32.55 to $33.15 per share, on August 01, 2014. Leonard still owns 1,002,778 shares of the company. Leonard operates out of Westlake Village, CA. Some additional info was provided as follows:

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires April 30, 2015. Shares held by Leonard Family Trust, dated August 28, 1996, Keith Richard Leonard, Jr. and Nanette LaRosa Leonard, Trustees. Shares held by Keith Richard Leonard, Jr., Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee. Shares held by Nanette LaRos a Leonard, Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee. Shares held by Keith R. Leonard III. Keith R. Leonard III is the son of the Reporting Person. Shares held by Nina R. Leonard. Nina R. Leonard is the daughter of the Reporting Person. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $32.33 to $32.78, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $32.85 to $33.63, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever KYTHERA Biopharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

KYTHERA Biopharmaceuticals's Chief Financial Officer just cashed-in 375 options - Oct. 20, 2014
KYTHERA Biopharmaceuticals director just disposed of 1,350 shares - Oct. 2, 2014
KYTHERA Biopharmaceuticals's President & CEO just disposed of 3,826 shares - Oct. 2, 2014

   Auto Refresh

Feedback